Ensign Peak Advisors’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,300
Closed -$56K 1964
2022
Q3
$56K Hold
6,300
﹤0.01% 2198
2022
Q2
$80K Hold
6,300
﹤0.01% 2006
2022
Q1
$119K Hold
6,300
﹤0.01% 1995
2021
Q4
$221K Hold
6,300
﹤0.01% 1903
2021
Q3
$231K Buy
6,300
+800
+15% +$31.5K ﹤0.01% 1738
2021
Q2
$216K Buy
5,500
+300
+6% +$8.66K ﹤0.01% 1716
2021
Q1
$147K Buy
5,200
+3,900
+300% +$124K ﹤0.01% 1753
2020
Q4
$42K Buy
+1,300
New +$40K ﹤0.01% 1821

Other funds holding HCM

Ensign Peak Advisors's HCM Position: Q4 2022 in Review

Ensign Peak Advisors sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 6,300 shares — an estimated $56K sold.

Ensign Peak Advisors first reported a position in HCM in Q4 2020 and held it in 8 quarters. The position peaked at $231K in Q3 2021. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Ensign Peak Advisors reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 6,300 HUTCHMED shares in Q4 2022, an estimated $56K.
  • Ensign Peak Advisors first reported a position in HUTCHMED in Q4 2020 and held it in 8 quarters.
  • Ensign Peak Advisors's HUTCHMED position peaked at $231K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.